Kezar Life Sciences Inc (KZR)

Finanzdaten der Kezar Life Sciences Inc-Aktie (KZR)

Gewinn- und Verlustrechnung

Vierteljährlich

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	7.00	-	-
Operating Expenses	31.45% 23.71	34.59	32.53	26.78	24.52
Interest Income/Expense	0.25% 0.40	0.399	0.396	0.385	0.37
Operating Income/Loss	31.45% -23.71	-34.59	-25.53	-26.78	-24.52
Income/Loss From Continuing Operations Before Tax	32.86% -21.66	-32.26	7.00	-24.31	-22.20
Income Tax Expense/Benefit	-	-	-	-	-
Income/Loss From Continuing Operations After Tax	32.86% -21.66	-32.26	-23.10	-24.31	-22.20
Net Income/Loss	32.86% -21.66	-32.26	-23.10	-24.31	-22.20
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	117.75K% 72.80	0.0618	72.68	72.46	72.33
Diluted Average Shares	117.75K% 72.80	0.0618	72.68	72.46	72.33
Basic Earnings Per Share	31.82% -0.30	-0.44	-0.32	-0.34	-0.31
Diluted Earnings Per Share	31.82% -0.30	-0.44	-0.32	-0.34	-0.31
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-